IRD financials

Opus Genetics (IRD) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

IRD income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$14.20M–-$38.60M-$49.59M-0.80
2024$10.99M–-$62.07M-$57.53M-2.15
2023$19.05M–-$10.56M-$9.99M-0.46
2022$39.85M–$18.23M$17.89M0.87
2021$589.00K–-$22.70M-$56.69M-3.82
2020$0.00–-$19.97M-$24.62M-5.28